The current analyst and expert consensus on DexCom is Buy with 1 strong sell and 12 strong buy opinions. The current projected target price consensus is 85.31 with 16 analysts opinions. The most common way DexCom Inc analysists use to provide recommendation to public is financial statements analysis. Many experts also interview DexCom executives and customers to further validate their buy or sell advice. DexCom buy or sell recommendation module provides average expert sentiment on the projected DexCom Inc target price to derive its highest and lowest estimates based on projected price volatility of 13.27. Additionally see Macroaxis Advice on DexCom to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the prospective of investor risk tolerance and investment horizon.